Impact of diabetes duration on achieved reductions in glycated haemoglobin, fasting plasma glucose and body weight with liraglutide treatment for up to 28 weeks: a meta‐analysis of...

por Seufert, J., Bailey, T., Barkholt Christensen, S., Nauck, M. A.
Publicado 2016

Insulin degludec does not increase antibody formation versus insulin glargine: an evaluation of phase IIIa trials

por Vora, J., Seufert, J., Solberg, H., Kinduryte, O., Johansen, T., Hollander, P.
Publicado 2016

Efficacy and safety of titrated canagliflozin in patients with type 2 diabetes mellitus inadequately controlled on metformin and sitagliptin

por Rodbard, H. W., Seufert, J., Aggarwal, N., Cao, A., Fung, A., Pfeifer, M., Alba, M.
Publicado 2016

HbA1c target achievement in the elderly: results of the Titration and Optimization trial for initiation of insulin glargine 100 U/mL in patients with type 2 diabetes poorly control...

por Fritsche, Andreas, Anderten, Helmut, Pfohl, Martin, Pscherer, Stefan, Borck, Anja, Pegelow, Katrin, Bramlage, Peter, Seufert, J
Publicado 2019

Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis

por Schernthaner, G., Barnett, A. H., Betteridge, D. J., Carmena, R., Ceriello, A., Charbonnel, B., Hanefeld, M., Lehmann, R., Malecki, M. T., Nesto, R., Pirags, V., Scheen, A., Seufert, J., Sjohölm, A., Tsatsoulis, A., DeFronzo, R.
Publicado 2010

Erratum to: Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis

por Schernthaner, G., Barnett, A. H., Betteridge, D. J., Carmena, R., Ceriello, A., Charbonnel, B., Hanefeld, M., Lehmann, R., Malecki, M. T., Nesto, R., Pirags, V., Scheen, A., Seufert, J., Sjöholm, Å., Tsatsoulis, A., DeFronzo, R.
Publicado 2010